[Propionibacterium granulosum KP-45 in the treatment of subacute sclerosing panencephalitis].
3 groups of patients, who suffered on SSPE (without treatment, with isoprinosine therapy, combined treatment with propionibacterium granulosum and isoprinosine) are compared. The results show a favourable effect of the combined treatment in a part of the patients. They are discussed in detail.
Sobczyk
W
W
Neurologische Abteilung Instituts für Psychiatrie und Neurologie, Warschau, VR Polen.
Kulczycki
J
J
Iwińska
B
B
Vainiene
M
M
Plachcińska
J
J
Szmigielskí
S
S
Pulverer
G
G
Jeliaszewicź
J
J
D000293:Adolescent; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002648:Child; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007262:Infusions, Intravenous; D007542:Inosine Pranobex / Q000008:administration & dosage; D007372:Interferons / Q000096:biosynthesis; D008213:Lymphocyte Activation; D008297:Male; D011424:Propionibacterium / Q000276:immunology*; D013190:SSPE Virus / Q000276:immunology; D013344:Subacute Sclerosing Panencephalitis / Q000276:immunology / Q000628:therapy*
D001428:Bacterial Vaccines; D007372:Interferons; D007542:Inosine Pranobex
Propionibacterium granulosum KP-45 in der Behandlung der Subakuten Sklerosierenden Panenzephalitis (SSPE).